Warning message

The subscription service is currently unavailable. Please try again later.

Neurotech Reports Cannabis In-Vitro Study Success

close up of marijauan plant

Australia’s Neurotech International Limited (ASX: NTI) has reported final results of in-vitro studies indicate its DOLCE/NTI cannabis strains exhibit potent anti-inflammatory activity.

Neurotech acquired an exclusive worldwide license to utilise proprietary cannabis strains from Dolce Cann Global, which it hopes could potentially be used to treat neurological disorders including autism, epilepsy and ADHD.

Neurotech’s analysis of 80 cannabis samples from the Dolce Cann Global revealed varying amounts of  cannabinoids including CBDV, CBDA, CBGA, CBG, CBD, THCV, CBN, THC, d8-THC, CBC and THCA – some of the many cannabinoids found in cannabis. CBDA was found to be present in particularly high levels.


Australia is Getting Over-the-Counter CBD in 2021…But Not Much

Map of australia featuring cannabis buds

Australia is now officially allowing for medical cannabis to be purchased from a pharmacy without even getting a prescription. However, it won’t happen right away, as there are currently no approved products available, and some would have liked to see more from this law. 


Australia Could Be One Of The Leading International Cannabis Markets In 2021

Marijuana plant



Australia is a legal cannabis market that rarely receives the attention it deserves and is a market that we are bullish on in 2021.

In 2019, we noticed a slowdown in interest in the Australian cannabis market as companies started to focus on the opportunity in Latin America. Since then, the Latin American cannabis market has not grown as much as expected while the Australian market has shown signs of strength. Article originally published on


Call For Cannabis As Medicine Survey 2020 Participants

marijuana leaf and bottle on a table

University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics is continuing its call for Australians to get involved in the Cannabis As Medicine Survey (CAMS) 2020 survey.

Similar surveys of Australians who have used cannabis for medical purposes within the previous 12 months were conducted in 2016 and 2018, and this latest survey aims to see how things have changed since the last CAMS.

The survey questions include requests for information on conditions medical cannabis is being used to treat or manage, access and administration, benefits or problems experienced and personal views on cannabis availability.


Australian researchers suggest loosening cannabis research rules could remove the cap on possibilities

marijuana plant

Anti-drug laws are putting a damper on fully exploring marijuana’s potential with respect to its possible health-helping benefits and how cannabis genomics may contribute to meeting that goal.

Researchers at Australia’s La Trobe University’s reviewed a raft of international studies of cannabis genomics and confirmed what many already believe.

Despite the many decades that cannabis has been studied, anti-drug laws are creating hurdles to identifying what scientists expect are weed’s unique medicinal properties, Mathew Lewsey, an associate professor at the university and the study’s lead researcher, suggests in a university statement.


Australian Natural Therapeutics Group receives cannabis oil manufacturing license

grower looking at marijuana plants in a greenhouse

NSW-based Australian Natural Therapeutics Group (ANTG) has been granted a license to produce large quantities of medicinal cannabis oil for commercial use as the industry booms on the back of good news internationally.

ANTG will commence commercial manufacturing of cannabis oil at its Armidale facility following receipt of the license from the Therapeutic Goods Administration.

Founded in 2015, ANTG already produces four strains of medicinal cannabis flower, and will soon add four oil combinations to its product range following.

ANTG CEO Matt Cantelo said the license signifies a big step in the buy-local movement and will mean price drops in medical cannabis as more of the drug is made on-shore.


Cannabidiol Without A Prescription In Australia: Update

CBD oil

There were hopes a (positive) TGA decision would be published last week in relation to over-the-counter cannabidiol (CBD) in Australia. Here’s what’s happening.

First, a recap of the road to this point.

Cannabidiol is a non-intoxicating (i.e., it doesn’t create a high) cannabinoid that can be extracted from hemp. CBD has been the focus of significant research into its potential for the treatment and/or management of a wide range of conditions.


Tasmanian Medical Cannabis Controlled Access Scheme “Shameful”

marijuana leaves

Tasmanian Greens MP Rosalie Woodruff has strongly criticised the State Government’s medical cannabis Controlled Access Scheme.

Introduced in 2017, the Scheme only enables medical specialists the ability to prescribe products to patients in circumstances where conventional treatments have failed. It’s a seven-step process:


Men allegedly caught carrying 85 kilograms of cannabis in the back of a truck


Two men have allegedly been caught carrying 85 kilograms of cannabis in the back of a truck on the NSW north coast.
Police stopped the 23-year-old driver and his 24-year-old passenger around 11.25pm on the Pacific Highway in Ewingsdale, for a traffic offence.

After speaking with the two men, police became suspicious and searched the back of the truck.
Officers allegedly found 186 packages of cannabis with a total weight of 85 kilograms.
The men were arrested charged with supply prohibited drug greater than commercial quantity, and drug possession.
Both men were refused bail and will appear before the court toady.


Australia’s cannabis sector can reach further highs in 2021 – here’s how it’ll happen

For Australia’s cannabis sector, 2021 is looking even better than what it did a few months ago.

Some also suffered from COVID-19 restrictions – and not just restrictions on people movements and falling consumer confidence.

Tommy Huppert, CEO of cultivator Cannatrek, told Stockhead moving freight was difficult in the early stages of COVID-19.

Given Australia’s cannabis sector heavily relies on imports, he didn’t mince his words.

“At one stage there were simply no flights so no medicine could arrive in the country, which was pretty scary,” Huppert declared.


Subscribe to RSS - Australia